Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM1 | P11229 | 1/20 | 0.43 |
| ▸ | AKR1A1 | P14550 | 1/20 | 0.43 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.43 |
| ▸ | HTR2A | P28223 | 1/20 | 0.43 |
| ▸ | HTR2C | P28335 | 1/20 | 0.43 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.43 |
| ▸ | HRH1 | P35367 | 1/20 | 0.43 |
| ▸ | DRD3 | P35462 | 1/20 | 0.43 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.43 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.43 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | FAAH | O00519 | 1/20 | 0.37 |
| ▸ | ACE2 | Q9BYF1 | 2/20 | 0.35 |
| ▸ | MME | P08473 | 1/20 | 0.35 |
| ▸ | ACE | P12821 | 1/20 | 0.35 |
| ▸ | CPA1 | P15085 | 1/20 | 0.35 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.34 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4944143 | 0.81 | CHRM1 (0.33) | CHRM1AKR1A1CHRM3HTR2AHTR2C | |
| SCHEMBL4654247 | 0.79 | FAAH (0.41) | CHRM1AKR1A1CHRM3HTR2AHTR2C | |
| SCHEMBL23011422 | 0.78 | CHRM1 (0.46) | CHRM1AKR1A1CHRM3HTR2AHTR2C | |
| SCHEMBL20981441 | 0.78 | CHRM1 (0.46) | CHRM1AKR1A1CHRM3HTR2AHTR2C | |
| SCHEMBL13889267 | 0.78 | CHRM1 (0.46) | CHRM1AKR1A1CHRM3HTR2AHTR2C | |
| SCHEMBL5940872 | 0.77 | CHRM1 (0.44) | CHRM1AKR1A1CHRM3HTR2AHTR2C | |
| SCHEMBL15375770 | 0.77 | CHRM1 (0.44) | CHRM1AKR1A1CHRM3HTR2AHTR2C | |
| SCHEMBL3836127 | 0.77 | CHRM1 (0.44) | CHRM1AKR1A1CHRM3HTR2AHTR2C | |
| SCHEMBL3836129 | 0.77 | CHRM1 (0.44) | CHRM1AKR1A1CHRM3HTR2AHTR2C | |
| SCHEMBL27767453 | 0.77 | CHRM1 (0.44) | CHRM1AKR1A1CHRM3HTR2AHTR2C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024103178-A1 | ANISOMYCIN ANALOGS AND USES THEREOF | Université de Montréal (CA) | 2024-05-23 | — | — | WO | disclosed |
| WO-2024050627-A1 | CSGA-DERIVED NANOSTRUCTURES AND USES THEREOF FOR ANTIGEN DELIVERY | BOURGAULT STEVE (CA) | 2024-03-14 | — | — | WO | disclosed |
| WO-2023039673-A1 | NOVEL TUMOR-SPECIFIC ANTIGENS FOR COLORECTAL CANCER AND USES THEREOF | Université de Montréal (CA) | 2023-03-23 | — | — | WO | disclosed |
| EP-4136099-A1 | NOVEL TUMOR-SPECIFIC ANTIGENS FOR ACUTE MYELOID LEUKEMIA (AML) AND USES THEREOF | Université de Montréal (CA) | 2023-02-22 | — | — | EP | disclosed |
| EP-4136100-A1 | NOVEL TUMOR-SPECIFIC ANTIGENS FOR ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) AND USES THEREOF | Université de Montréal (CA) | 2023-02-22 | — | — | EP | disclosed |
| EP-3990483-A1 | NOVEL TUMOR-SPECIFIC ANTIGENS FOR OVARIAN CANCER AND USES THEREOF | Université de Montréal (CA) | 2022-05-04 | — | — | EP | disclosed |
| WO-2022000066-A1 | SELF-ASSEMBLED PEPTIDE NANORODS AND USES THEREOF | TRANSFERT PLUS, SOCIÉTÉ EN COMMANDITE (CA) | 2022-01-06 | — | — | WO | disclosed |
| WO-2021207823-A1 | NOVEL TUMOR-SPECIFIC ANTIGENS FOR ACUTE MYELOID LEUKEMIA (AML) AND USES THEREOF | Université de Montréal (CA) | 2021-10-21 | — | — | WO | disclosed |
| WO-2021207826-A1 | NOVEL TUMOR-SPECIFIC ANTIGENS FOR ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) AND USES THEREOF | Université de Montréal (CA) | 2021-10-21 | — | — | WO | disclosed |
| EP-3844172-A1 | PROTEOGENOMIC-BASED METHOD FOR IDENTIFYING TUMOR-SPECIFIC ANTIGENS | Université de Montréal (CA) | 2021-07-07 | — | — | EP | disclosed |
| EP-2828280-A1 | PLIF MULTIMERIC PEPTIDES AND USES THEREOF | Ramot at Tel-Aviv University Ltd. (IL) | 2015-01-28 | — | — | EP | disclosed |
| WO-2014118785-A1 | GENERATION OF CYTOTOXIC TUMOR SPECIFIC CELL LINES AND USES THEREOF | RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) | 2014-08-07 | — | — | WO | disclosed |
| EP-2751132-A2 | ADHESIVE BIOPOLYMERS AND USES THEREOF | Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. (IL) | 2014-07-09 | — | — | EP | disclosed |
| EP-2699591-A1 | GROWTH HORMONE RELEASING FACTOR (GRF) ANALOGS AND USES THEREOF | Theratechnologies Inc. (CA) | 2014-02-26 | — | — | EP | disclosed |
| WO-2013183048-A1 | FUNCTIONALIZED TITANIUM BINDING PEPTIDES AND IMPLANTS COATED WITH SAME | BEN-GURION UNIVERSITY OF THE NEGEV RESEARCH AND DEVELOPMENT AUTHORITY (IL) | 2013-12-12 | — | — | WO | disclosed |
| WO-2013168164-A1 | VARIANTS OF TACE PRO-DOMAIN AS TNF-A INHIBITOR AND THEIR MEDICAL USE | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2013-11-14 | — | — | WO | disclosed |
| WO-2013140389-A1 | PLIF MULTIMERIC PEPTIDES AND USES THEREOF | RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) | 2013-09-26 | — | — | WO | disclosed |
| WO-2013030840-A2 | ADHESIVE BIOPOLYMERS AND USES THEREOF | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2013-03-07 | — | — | WO | disclosed |
| WO-2012142706-A1 | GROWTH HORMONE RELEASING FACTOR (GRF) ANALOGS AND USES THEREOF | THERATECHNOLOGIES INC. (CA) | 2012-10-26 | — | — | WO | disclosed |
| WO-2008128038-A2 | METHODS AND COMPOSITIONS FOR TREATING CARDIAC DYSFUNCTIONS | THE SCRIPPS RESEARCH INSTITUTE (US) | 2008-10-23 | — | — | WO | disclosed |